Antitumor events were promoted by the miR-34a-5p/HMGB1 axis in acute myeloid leukemia [96], cutaneous squamous cell carcinoma [72], cervical cancer, and colorectal cancers [71], and similar effects were exerted by miR-34a-3p/HMGB1 in retinoblastoma [70]. This evidence concerns the gene HMGB1 and cervical cancer.